Zhou, Ly., Shan, Zz. & You, Jl. Clinical observation on treatment of colonic cancer with combined treatment of chemotherapy and Chinese herbal medicine., Chin. J. Integr. Med. 15, 107–111 (2009). https://doi.org/10.1007/s11655-009-0107-y
Liu-yong Zhou, Zhen-zhu Shan, Jian-liang You. Clinical observation on treatment of colonic cancer with combined treatment of chemotherapy and Chinese herbal medicine[J]. Chinese Journal of Integrative Medicine, 2009,15(2):107-111.
Zhou, Ly., Shan, Zz. & You, Jl. Clinical observation on treatment of colonic cancer with combined treatment of chemotherapy and Chinese herbal medicine., Chin. J. Integr. Med. 15, 107–111 (2009). https://doi.org/10.1007/s11655-009-0107-yDOI:
Liu-yong Zhou, Zhen-zhu Shan, Jian-liang You. Clinical observation on treatment of colonic cancer with combined treatment of chemotherapy and Chinese herbal medicine[J]. Chinese Journal of Integrative Medicine, 2009,15(2):107-111. DOI: 10.1007/s11655-009-0107-y.
Clinical observation on treatment of colonic cancer with combined treatment of chemotherapy and Chinese herbal medicine
摘要
To observe the clinical effect of combined chemotherapy and Chinese herbal medicine in treating colonic cancer. One hundred and sixty-three patients were assigned
according to their will
to two groups
105 in the traditional Chinese medicine treated group (Group A) and 58 in the combined treatment group (Group B). The Chinese herbal drug Zhao’s Weitiao No. 3 (赵氏微调 3号方
ZW3) was given to both groups
twice a day
40 mL each time
30 days as one cycle
and over 6 cycles applied in total. For patients in Group B
the chemotherapy of OLF protocol (L-OHP+LV+5-FU) was given for 4–6 cycles. The effects of treatment on the main symptoms
tumor mass
patients’ quality of life (QOL) and body weight
changes of carcino-embryonic antigen (CEA)
as well as the integral effect and survival rate were observed and compared. The total effective rate in Group A and Group B was 89.52% and 86.21% respectively
on the main clinical symptoms; 86.67% and 93.10% on tumor mass
82.86% and 77.59% on QOL
85.71% and 75.86% on body weight and 76.19% and 79.31% on CEA. The integral efficacy of total beneficial rate was 73.33% and 68.97%; and the 3-year survival rate 49.52% and 46.65% in Group A and Group B. These data showed that the effect in Group A was better than in Group B in terms of clinical symptom improvement
QOL
body weight and integral beneficence increase and survival rate
though it was inferior in reducing the tumor mass and CEA level. Chinese drug ZW3 for the treatment of colonic cancer could improve the main clinical symptoms
improve the QOL
increase body weight and prolong the survival time of patients
showing a favorable integral effect.
Abstract
To observe the clinical effect of combined chemotherapy and Chinese herbal medicine in treating colonic cancer. One hundred and sixty-three patients were assigned
according to their will
to two groups
105 in the traditional Chinese medicine treated group (Group A) and 58 in the combined treatment group (Group B). The Chinese herbal drug Zhao’s Weitiao No. 3 (赵氏微调 3号方
ZW3) was given to both groups
twice a day
40 mL each time
30 days as one cycle
and over 6 cycles applied in total. For patients in Group B
the chemotherapy of OLF protocol (L-OHP+LV+5-FU) was given for 4–6 cycles. The effects of treatment on the main symptoms
tumor mass
patients’ quality of life (QOL) and body weight
changes of carcino-embryonic antigen (CEA)
as well as the integral effect and survival rate were observed and compared. The total effective rate in Group A and Group B was 89.52% and 86.21% respectively
on the main clinical symptoms; 86.67% and 93.10% on tumor mass
82.86% and 77.59% on QOL
85.71% and 75.86% on body weight and 76.19% and 79.31% on CEA. The integral efficacy of total beneficial rate was 73.33% and 68.97%; and the 3-year survival rate 49.52% and 46.65% in Group A and Group B. These data showed that the effect in Group A was better than in Group B in terms of clinical symptom improvement
QOL
body weight and integral beneficence increase and survival rate
though it was inferior in reducing the tumor mass and CEA level. Chinese drug ZW3 for the treatment of colonic cancer could improve the main clinical symptoms
improve the QOL
increase body weight and prolong the survival time of patients
showing a favorable integral effect.
关键词
Chinese Herbal MedicinechemotherapyClinical Observation
Keywords
Chinese Herbal MedicinechemotherapyClinical Observation
references
Chinese Anti-cancer Association. Norm for diagnosis and treatment of malignant tumor commonly encountered in China. 1st ed. Beijing: Chinese Academy of Medical Sciences and Peking Union Medical College Press; 1991:117–139.
Greene FL, Peggy DL, Flemling ID, ed. Mao WZ, S DM, Li XP, Chen JQ, translator. Handbook for AJCC cancer staging. 6th ed. Shenyang: Liaoning Science and Technology Publishing House; 2005:113–116.
Zheng XY, ed. Guiding principle of clinical research on new drugs of TCM. Beijing: China Medic-Pharmaceutical Sciences and Technology Publishing House; 2002:124–153, 207–224.
Sun Y, ed. Tumor of internal medicine. Beijing: People’s Medical Publishing House; 2001: 994, 996.
Lin HS, Li SQ, Piao BK. Efficacy evaluation method of TCM treatment on advanced lung cancer. China Cancer 2000;9:354–355.
Cheng Y. Status of internal medicine treatment on colon carcinoma. J Pract Oncol (Chin) 2002;16:69.
Clinical observation on the combined treatment of 57 cases of non-small cell lung cancer using argon-helium cryosurgery and Chinese herbal medicine
Development is a high level inheritance for China Time-honored Brand products
Effect of Chinese herbal medicine for nourishing yin, supplementing qi, and activating blood on the Th1/Th2 immune balance in peripheral blood in patients with primary Sjogren’s syndrome
The treatment of non-small cell lung cancer by interstitial I-125 seeds implantation combined with chemotherapy and Chinese medicine
Chinese herbal medicine in the treatment of nonalcoholic fatty liver disease
相关作者
暂无数据
相关机构
Tumor Department, Dongfang Hospital, Beijing University of Chinese Medicine
Cardiovascular Diseases Centre, Xiyuan Hospital, China Academy of Chinese Medical Sciences
The First Affiliated Hospital of Medical College of Zhejiang University
Zhejiang University of Chinese Medicine
Department of Traditional Chinese Medicine, Chinese People’s Liberation Army General Hospital